Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 22;58(7):838.
doi: 10.3390/medicina58070838.

Future Acceptability of Respiratory Virus Infection Control Interventions in General Population to Prevent Respiratory Infections

Affiliations

Future Acceptability of Respiratory Virus Infection Control Interventions in General Population to Prevent Respiratory Infections

Jaber S Alqahtani et al. Medicina (Kaunas). .

Abstract

Background and Objectives: In both pandemic and non-pandemic situations, nonpharmaceutical public health measures may offer easy, low-cost, and effective means of reducing the spread and impact of acute respiratory infections. It is unknown whether such measures would be acceptable to the Saudi community beyond the current pandemic. Materials and Methods: A validated survey was used to test community acceptance of the measures. Respondents were asked which infection control practices they planned to maintain and which they believed should be policies for the community as a whole after the COVID-19 pandemic has subsided. Results: The survey was completed by 2057 people (95% completion rate), 1486 (72%) of whom were female, 259 (12.5%) of whom were current smokers, and 72 (3.5%) of whom had chronic lung disease. The most prevalent age groups were 18−30 years (933; 45.4%) and 31−40 years (483; 23.5%), with 641 individuals over 40 years old. Of the responses, 93% indicated that they would continue washing their hands more often; 92% wanted both clinicians and patients to wear masks in hospitals; 86% would continue avoiding smoking in indoor and outdoor areas; 73% would continue wearing a face covering on public transportation; 70% indicated that they would continue wearing a face covering in indoor public places. Regarding the respiratory virus infection control measures, 85% (11/13) received significant support (≥70% acceptability level) for continuation as policies in the future. Wearing face coverings outdoors and social distancing outdoors received little support (45% and 66%, respectively). Of the respiratory virus infection control measures, 54% received less support from current smokers than non-smokers (acceptability level < 70%). People with chronic respiratory disease supported 77% of the measures being regarded as policies in the future. Conclusion: The Saudi community supports nonpharmacological respiratory infection control measures that reduce the likelihood of infection. Public health campaigns should target smokers to increase awareness of the importance of these measures in lowering infections. Based on the findings of this study, nonpharmacological treatments should be presented and included in future recommendations for both the public and patients diagnosed with chronic respiratory diseases.

Keywords: COVID; public health; respiratory infections; smoking; social distance.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
The acceptability of policies regarding respiratory virus infection control interventions by age.
Figure 2
Figure 2
The acceptability of future policies for everyone at all times regarding respiratory virus infection control interventions by age.
Figure 3
Figure 3
The acceptability of future policies for everyone at all times regarding respiratory virus infection control interventions by smoking status.
Figure 4
Figure 4
The acceptability of respiratory virus infection control interventions in people with chronic respiratory disease, including if there will be policies in the future or not.

References

    1. WHO Coronavirus Disease (COVID-2019) Situation Report 2020. 2019. [(accessed on 20 May 2022)]. Available online: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-a....
    1. Meo S.A., Alhowikan A.M., Al-Khlaiwi T., Meo I.M., Halepoto D.M., Iqbal M., Usmani A.M., Hajjar W., Ahmed N. Novel coronavirus 2019-nCoV: Prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV. Eur. Rev. Med. Pharmacol. Sci. 2020;24:2012–2019. - PubMed
    1. Waseem R., Ullah I., Irfan M., Dominari A., Elmahi O.K.O., Tahir M.J. MERS and COVID-19: A double burden for the healthcare system of Saudi Arabia. Health Sci. Rep. 2022;5:e2515. doi: 10.1002/hsr2.515. - DOI - PMC - PubMed
    1. Teasdale E., Santer M., Geraghty A.W., Little P., Yardley L. Public perceptions of non-pharmaceutical interventions for reducing transmission of respiratory infection: Systematic review and synthesis of qualitative studies. BMC Public Health. 2014;14:589. doi: 10.1186/1471-2458-14-589. - DOI - PMC - PubMed
    1. Idris I.O., Ayeni G.O., Adebisi Y.A. Why many African countries may not achieve the 2022 COVID-19 vaccination coverage target. Trop. Med. Health. 2022;50:15. doi: 10.1186/s41182-022-00407-6. - DOI - PMC - PubMed